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http://intl.elsevierhealth.com/journals/ijidTable 1 Distribution of positive influenza specimens iden-
tified by rapid antigen detection
Virus type Specimens % (n) Outbreaks % (n)
Influenza A 67 (34) 81 (17)
Influenza A/B 100 (1) 50 (2)
Influenza B 48 (30) 68 (17)
Either influenza A or B 56 (65) * 72 (36) *
* Rapid antigen testing was more effective at characterizing
outbreaks than individual specimens (p < 0.05).Utility of the BD Directigen Flu A+B rapid anti-
gen detection assay as an influenza outbreak
detection tool
To the editor,
Rapid antigen detection tests for influenza have low clin-
ical sensitivity compared with reference methodologies
(e.g. molecular methods and culture) when used to assist
in the diagnosis of influenza in individual patients.1,2 In
contrast, molecular diagnostic tools offer greater analyti-
cal sensitivity and specificity, but might be hampered by a
requirement for expensive technology and a work-force
comfortable with high-complexity testing.3,4 Given these
concerns, the authors postulate that rapid antigen tests
could still retain some usefulness when used to diagnose
the etiology of outbreaks, rather than individual or spora-
dic cases. The purpose of this study was to compare the
ability of the BD Directigen Flu A+B rapid antigen detection
assay to detect influenza in both individual specimens and
outbreaks.
Respiratory infection outbreaks in long-term care facil-
ities are defined as a cluster of clinical cases in either long-
term care facilities or acute care facilities that meet local
public health definitions. Specimens were collected using the
flocculated Starswab1 Multitrans Collection and Transport
System (Starplex, Bolton, ON, Canada). All specimens were
tested by PCR using the Seeplex1 RV detection kit protocol
(Seegene, Inc., Rockville, MD, USA) for influenza A and
influenza B3, and by antigen detection using the BD Directi-
gen Flu A+B assay (Oakville, ON, Canada), following the
respective manufacturers’ protocols. For the Seeplex1 RV
assay, total nucleic acid was extracted from each specimen
using the easyMag automated extraction system (bioMe´rieux,
Montreal, QC, Canada). Specimens were also cultured on
rhesus monkey kidney cells (Diagnostic Hybrids, Athens, OH,
USA) in atmospheric air for ten days, followed by post-culture
direct fluorescence antibody staining for influenza A and
influenza B (Diagnostic Hybrids, Athens, OH, USA). One-sided
Fisher’s exact test and other statistics were performed using
GraphPad Prism 5.
Specimens were defined as follows: laboratory-confirmed
positive specimen –— a specimen with two or more influenza-
positive test results; laboratory-confirmed positive outbreak
–— defined respiratory outbreak with one or more influenza-
positive specimens.1201-9712/$36.00. Crown Copyright# 2009 Published by Elsevier Ltd on be
doi:10.1016/j.ijid.2008.12.007A total of 465 specimens from 139 outbreaks were ana-
lyzed, with a median number of 4 specimens analyzed per
outbreak (range 1—7 specimens). Using the definitions
described above, the distribution of influenza-positive speci-
mens (n = 115) was: 44% (n = 51/115) influenza A; 1% (n = 1/
115) influenza A/B; 55% (n = 63/115) influenza B. For speci-
mens, the rapid antigen test sensitivity was: influenza A 67%
(n = 34/51); influenza A/B 100% (n = 1/1); influenza B 48%
(n = 30/63) (Table 1). The distribution of positive outbreaks
was: 42% (n = 21/50) influenza A; 8% (n = 4/50) influenza A/B;
50% (n = 25/50) influenza B. For combined influenza A/B
detection, rapid antigen testing was more effective at char-
acterizing outbreaks (72%, n = 36/50) than individual speci-
mens (56%, n = 65/115) ( p < 0.05).
The emerging literature and the authors’ own laboratory
experience suggest that, although the sensitivity of influenza
rapid antigen assays is not ideal, these assays might still be
useful as tools for the characterization of outbreaks, rather
than individual specimens, when influenza has been identi-
fied in a community.5 This approach to the use of antigen-
based detection methods in outbreak settings involving other
viral pathogens (e.g. norovirus) has been previously
described.6 Briefly, the analysis of multiple specimens linked
to a defined outbreak, instead of individual specimen ana-
lysis, increases the probability of detection of viral patho-
gens, even when an antigen-based detection methodology
with low sensitivity is used.6 As long as patients providing
specimens are truly clinically and epidemiologically linked to
an outbreak, diagnosis is then focused on the outbreak speci-
mens as a group, instead of individual patient specimens. It
should be noted, however, that this study focuses only on the
role of rapid antigen tests in the diagnosis of influenza out-
breaks and does not directly address the role of rapid influ-
enza tests in antiviral treatment strategies.7,8half of International Society for Infectious Diseases. All rights reserved.
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